Analysts expect Marsh & McLennan (NYSE: MMC) to deliver approximately 21% growth by 2027, supported by continued momentum and strong demand in its insurance and consulting businesses.
Over the past year, Marsh & McLennan’s stock price declined from nearly $248 to around $177 per share. This drop reflects broader market volatility rather than fundamental business concerns. Despite the decline, the company has maintained steady performance driven by solid client demand.
Earlier this year, the firm raised its quarterly dividend, demonstrating management’s confidence in long-term profitability and cash flow stability.
The average analyst target for Marsh & McLennan stands near $214 per share, indicating an upside of roughly 21% from current levels around $177.
According to TIKR’s Guided Valuation Model and analyst consensus, the expected appreciation reflects a stable business outlook and enduring demand across core segments.
Analysts forecast around 21% upside for Marsh & McLennan by 2027, underscoring faith in its resilient insurance and consulting operations.